Symbols / AQST $4.26 -1.84% Aquestive Therapeutics, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
AQST Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 506.49M Enterprise Value — Income — Sales — Book/sh — Cash/sh —
Dividend Yield — Payout — Employees — IPO — P/E — Forward P/E —
PEG — P/S — P/B — P/C — EV/EBITDA — EV/Sales —
Quick Ratio — Current Ratio — Debt/Eq — LT Debt/Eq — EPS (ttm) — EPS next Y —
EPS Growth — Revenue Growth — Earnings — ROA — ROE — ROIC —
Gross Margin — Oper. Margin — Profit Margin — Shs Outstand — Shs Float — Short Float —
Short Ratio — Short Interest — 52W High — 52W Low — Beta — Avg Volume —
Volume — Target Price — Recom — Prev Close $4.34 Price $4.26 Change -1.84%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest AQST news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
44.55
-22.61%
57.56
+13.80%
50.58
+6.09%
47.68
Operating Revenue
44.55
-22.61%
57.56
+13.80%
50.58
+6.09%
47.68
Cost Of Revenue
18.55
+3.82%
17.87
-14.20%
20.83
+7.45%
19.39
Reconciled Cost Of Revenue
18.55
+3.82%
17.87
-14.20%
20.83
+7.45%
19.39
Gross Profit
25.99
-34.52%
39.69
+33.40%
29.75
+5.15%
28.29
Operating Expense
97.04
+37.72%
70.46
+57.09%
44.85
-36.25%
70.36
Research And Development
17.19
-15.23%
20.28
+54.76%
13.10
-25.04%
17.48
Selling General And Administration
79.85
+59.13%
50.18
+58.05%
31.75
-39.96%
52.88
Total Expenses
115.60
+30.87%
88.33
+34.48%
65.69
-26.81%
89.75
Operating Income
-71.05
-130.90%
-30.77
-103.75%
-15.10
+64.10%
-42.07
Total Operating Income As Reported
-71.05
-130.90%
-30.77
-103.75%
-15.10
+64.10%
-42.07
EBITDA
-66.14
-148.48%
-26.62
-2351.78%
1.18
+102.99%
-39.58
Normalized EBITDA
-66.14
-148.48%
-26.62
-1138.07%
2.56
+106.48%
-39.58
Reconciled Depreciation
0.55
-23.68%
0.72
-46.62%
1.34
-43.65%
2.39
EBIT
-66.68
-143.96%
-27.33
-16669.33%
-0.16
+99.61%
-41.97
Total Unusual Items
—
0.00
+100.00%
-1.38
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-1.38
0.00
Special Income Charges
—
0.00
+100.00%
-1.38
0.00
Other Special Charges
—
—
1.38
—
Net Income
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Pretax Income
-83.78
-89.77%
-44.15
-479.03%
-7.62
+85.99%
-54.41
Net Non Operating Interest Income Expense
-12.73
+4.84%
-13.38
-251.03%
8.86
+171.77%
-12.34
Interest Expense Non Operating
17.10
+1.68%
16.82
+125.37%
7.46
-40.03%
12.44
Net Interest Income
-12.73
+4.84%
-13.38
-251.03%
8.86
+171.77%
-12.34
Interest Expense
17.10
+1.68%
16.82
+125.37%
7.46
-40.03%
12.44
Interest Income Non Operating
4.37
+27.06%
3.44
-78.94%
16.32
+16385.86%
0.10
Interest Income
4.37
+27.06%
3.44
-78.94%
16.32
+16385.86%
0.10
Other Income Expense
—
—
-1.38
—
Tax Provision
0.00
+100.00%
-0.01
-105.71%
0.24
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
-99.85%
0.00
+104900.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.29
0.00
Net Income Including Noncontrolling Interests
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Net Income From Continuing Operation Net Minority Interest
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Net Income From Continuing And Discontinued Operation
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Net Income Continuous Operations
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Normalized Income
-83.78
-89.83%
-44.14
-551.16%
-6.78
+87.54%
-54.41
Net Income Common Stockholders
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Diluted EPS
—
-0.51
-292.31%
-0.13
+88.39%
-1.12
Basic EPS
—
-0.51
-292.31%
-0.13
+88.39%
-1.12
Basic Average Shares
—
86.73
+41.58%
61.26
+25.69%
48.73
Diluted Average Shares
—
86.73
+41.58%
61.26
+25.69%
48.73
Diluted NI Availto Com Stockholders
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Line Item Trend 2023-12-31
Total Assets
57.42
Current Assets
40.97
Cash Cash Equivalents And Short Term Investments
23.87
Cash And Cash Equivalents
23.87
Receivables
8.47
Accounts Receivable
5.57
Receivables Adjustments Allowances
-0.01
Other Receivables
2.92
Inventory
6.77
Raw Materials
2.12
Finished Goods
1.62
Prepaid Assets
—
Other Current Assets
1.85
Total Non Current Assets
16.45
Net PPE
9.74
Gross PPE
52.62
Accumulated Depreciation
-42.88
Properties
0.00
Machinery Furniture Equipment
23.64
Construction In Progress
2.03
Other Properties
5.56
Leases
21.39
Goodwill And Other Intangible Assets
1.28
Other Intangible Assets
1.28
Non Current Accounts Receivable
4.00
Other Non Current Assets
1.44
Total Liabilities Net Minority Interest
163.91
Current Liabilities
18.31
Payables And Accrued Expenses
11.22
Payables
9.26
Accounts Payable
8.93
Current Accrued Expenses
1.96
Pensionand Other Post Retirement Benefit Plans Current
4.20
Total Tax Payable
0.34
Current Debt And Capital Lease Obligation
0.41
Current Debt
0.02
Other Current Borrowings
0.02
Current Capital Lease Obligation
0.39
Current Deferred Liabilities
1.55
Current Deferred Revenue
1.55
Other Current Liabilities
0.92
Total Non Current Liabilities Net Minority Interest
145.60
Liabilities Heldfor Sale Non Current
63.57
Long Term Debt And Capital Lease Obligation
32.91
Long Term Debt
27.51
Long Term Capital Lease Obligation
5.40
Non Current Deferred Liabilities
32.34
Non Current Deferred Revenue
32.34
Other Non Current Liabilities
16.78
Stockholders Equity
-106.49
Common Stock Equity
-106.49
Capital Stock
0.07
Common Stock
0.07
Share Issued
68.53
Ordinary Shares Number
68.53
Treasury Shares Number
0.00
Additional Paid In Capital
212.52
Retained Earnings
-319.08
Total Equity Gross Minority Interest
-106.49
Total Capitalization
-78.98
Working Capital
22.66
Invested Capital
-78.96
Total Debt
33.32
Net Debt
3.66
Capital Lease Obligations
5.79
Net Tangible Assets
-107.77
Tangible Book Value
-107.77
Interest Payable
1.01
Other Inventories
3.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-52.43
-46.63%
-35.76
-460.49%
-6.38
+35.02%
-9.82
Cash Flow From Continuing Operating Activities
-52.43
-46.63%
-35.76
-460.49%
-6.38
+35.02%
-9.82
Net Income From Continuing Operations
-83.78
-89.83%
-44.14
-460.83%
-7.87
+85.54%
-54.41
Depreciation Amortization Depletion
0.55
-23.68%
0.72
-46.62%
1.34
-43.65%
2.39
Depreciation
0.55
-14.37%
0.64
-52.42%
1.34
-43.65%
2.39
Amortization Cash Flow
—
0.08
—
—
Depreciation And Amortization
0.55
-23.68%
0.72
-46.62%
1.34
-43.65%
2.39
Amortization Of Intangibles
—
0.08
—
—
Other Non Cash Items
11.00
+4.54%
10.52
+494.91%
1.77
-69.76%
5.85
Stock Based Compensation
7.62
+7.40%
7.10
+164.00%
2.69
-38.62%
4.38
Operating Gains Losses
—
—
1.03
—
Change In Working Capital
12.18
+222.37%
-9.96
-86.43%
-5.34
-116.70%
31.98
Change In Receivables
-10.37
-1048.08%
1.09
+135.60%
-3.07
-141.80%
7.35
Change In Inventory
-0.13
-117.38%
0.72
+173.31%
-0.99
+43.26%
-1.74
Change In Prepaid Assets
0.70
+413.00%
-0.22
-117.29%
1.29
-7.79%
1.40
Change In Payables And Accrued Expense
22.55
+1648.45%
1.29
+136.49%
-3.54
-4677.03%
-0.07
Change In Accrued Expense
3.03
+303.22%
-1.49
+40.68%
-2.52
-5.58%
-2.38
Change In Payable
19.52
+601.76%
2.78
+372.75%
-1.02
-144.19%
2.31
Change In Account Payable
19.52
+601.76%
2.78
+372.75%
-1.02
-162.46%
1.63
Change In Other Working Capital
-0.57
+95.55%
-12.84
-1429.50%
0.97
-96.14%
25.04
Change In Other Current Liabilities
—
—
—
0.68
Investing Cash Flow
-0.56
-253.46%
-0.16
+84.02%
-0.99
+60.58%
-2.52
Cash Flow From Continuing Investing Activities
-0.56
-253.46%
-0.16
+84.02%
-0.99
+60.58%
-2.52
Capital Expenditure
-0.56
-253.46%
-0.16
+84.02%
-0.99
+60.58%
-2.52
Capital Expenditure Reported
-0.56
-253.46%
-0.16
+84.02%
-0.99
+2.83%
-1.02
Net Intangibles Purchase And Sale
—
—
0.00
+100.00%
-1.50
Purchase Of Intangibles
—
—
0.00
+100.00%
-1.50
Financing Cash Flow
102.62
+22.76%
83.59
+2003.47%
3.97
-65.72%
11.59
Cash Flow From Continuing Financing Activities
102.62
+22.76%
83.59
+2003.47%
3.97
-65.72%
11.59
Net Issuance Payments Of Debt
-0.03
-13.04%
-0.02
+99.90%
-22.49
-1010.47%
-2.02
Issuance Of Debt
—
0.00
-100.00%
31.14
0.00
Repayment Of Debt
-0.03
-13.04%
-0.02
+99.96%
-53.63
-2548.44%
-2.02
Long Term Debt Issuance
—
0.00
-100.00%
31.14
0.00
Long Term Debt Payments
-0.03
-13.04%
-0.02
+99.96%
-53.63
-2548.44%
-2.02
Net Long Term Debt Issuance
-0.03
-13.04%
-0.02
+99.90%
-22.49
-1010.47%
-2.02
Net Common Stock Issuance
100.65
+20.17%
83.76
+839.82%
8.91
-34.40%
13.59
Proceeds From Stock Option Exercised
2.81
+191.49%
0.96
-88.45%
8.35
+24450.00%
0.03
Net Other Financing Charges
-0.82
+25.77%
-1.11
-112.02%
9.20
+306833.33%
-0.00
Changes In Cash
49.62
+4.09%
47.67
+1501.76%
-3.40
-352.86%
-0.75
Beginning Cash Position
71.55
+199.71%
23.87
-12.47%
27.27
-2.68%
28.02
End Cash Position
121.17
+69.36%
71.55
+199.71%
23.87
-12.47%
27.27
Free Cash Flow
-52.99
-47.54%
-35.92
-387.02%
-7.38
+40.25%
-12.34
Interest Paid Supplemental Data
6.10
-14.08%
7.10
+54.22%
4.60
-28.50%
6.44
Income Tax Paid Supplemental Data
0.00
-100.00%
0.30
0.00
—
Common Stock Issuance
100.65
+20.17%
83.76
+839.82%
8.91
-34.40%
13.59
Issuance Of Capital Stock
100.65
+20.17%
83.76
+839.82%
8.91
-34.40%
13.59
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category